Shukra Pharmaceuticals Ltd.
BSE: 524632 | Sector: Health care |
NSE: N.A. | ISIN Code: INE551C01028 |
BSE 00:00 | 30 Jan | 238.20 |
11.30 (4.98%) |
OPEN
238.20 |
HIGH
238.20 |
LOW
227.00 |
NSE 05:30 | 01 Jan | Shukra Pharmaceuticals Ltd |
OPEN | 238.20 |
PREVIOUS CLOSE | 226.90 |
VOLUME | 17548 |
52-Week high | 238.20 |
52-Week low | 53.50 |
P/E | 33.93 |
Mkt Cap.(Rs cr) | 37 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Shukra Pharmaceuticals Ltd. (SHUKRAPHARMA) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 1050.90 | 7.30 | 0.70 | 15585.98 |
Dr Reddy's Labs | 4331.45 | 13.15 | 0.30 | 14405.20 |
Cipla | 1034.80 | -12.25 | -1.17 | 13091.79 |
Lupin | 734.40 | -7.80 | -1.05 | 11771.67 |
Aurobindo Pharma | 411.60 | -4.65 | -1.12 | 11287.14 |
Divi's Lab. | 3367.35 | -18.20 | -0.54 | 8879.82 |
Alkem Lab | 3007.40 | 9.80 | 0.33 | 8829.81 |
Glenmark Pharma. | 371.10 | -10.30 | -2.70 | 8141.58 |
Zydus Lifesci. | 427.90 | -2.35 | -0.55 | 7981.90 |
Torrent Pharma. | 1547.65 | 9.85 | 0.64 | 6742.32 |
Apollo Hospitals | 4238.30 | -5.00 | -0.12 | 6098.30 |
Ipca Labs. | 855.35 | 4.75 | 0.56 | 5399.36 |
Alembic Pharma | 537.30 | -0.80 | -0.15 | 5035.41 |
Abbott India | 20967.75 | -252.10 | -1.19 | 4919.27 |
Laurus Labs | 341.85 | 0.00 | 0.00 | 4707.04 |
Gland Pharma | 1309.95 | -47.15 | -3.47 | 4400.71 |
Granules India | 291.25 | 7.15 | 2.52 | 3238.44 |
Glaxosmi. Pharma | 1258.65 | -2.95 | -0.23 | 3217.51 |
Ajanta Pharma | 1207.90 | 26.05 | 2.20 | 3140.64 |
Piramal Pharma | 101.95 | -0.95 | -0.92 | 3094.95 |
Quick Links for Shukra Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices